These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 164704

  • 1. Incidence of paramalignant disorders in bronchogenic carcinoma.
    Rassam JW, Anderson G.
    Thorax; 1975 Feb; 30(1):86-90. PubMed ID: 164704
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of digital clubbing in bronchogenic carcinoma by a new digital index.
    Baughman RP, Gunther KL, Buchsbaum JA, Lower EE.
    Clin Exp Rheumatol; 1998 Feb; 16(1):21-6. PubMed ID: 9543557
    [Abstract] [Full Text] [Related]

  • 3. Endocrine and metabolic disordes in bronchial carcinoma.
    Azzopardi JG, Freeman E, Poole G.
    Br Med J; 1970 Nov 28; 4(5734):528-30. PubMed ID: 5483322
    [Abstract] [Full Text] [Related]

  • 4. Hypertrophic pulmonary osteoarthropathy.
    Stenseth JH, Clagett OT, Woolner LB.
    Dis Chest; 1967 Jul 28; 52(1):62-8. PubMed ID: 6029044
    [No Abstract] [Full Text] [Related]

  • 5. Delayed onset of secondary hypertrophic osteoarthropathy.
    Perkins PJ.
    AJR Am J Roentgenol; 1978 Mar 28; 130(3):561-2. PubMed ID: 204179
    [No Abstract] [Full Text] [Related]

  • 6. Incidence of hypertrophic pulmonary osteoarthropathy associated with primary lung cancer.
    Izumi M, Takayama K, Yabuuchi H, Abe K, Nakanishi Y.
    Respirology; 2010 Jul 28; 15(5):809-12. PubMed ID: 20497387
    [Abstract] [Full Text] [Related]

  • 7. Hypertrophic osteoarthropathy, phalangeal and synovial metastases associated with bronchogenic carcinoma.
    Fam AG, Cross EG.
    J Rheumatol; 1979 Jul 28; 6(6):680-6. PubMed ID: 529251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pulmonary hypertrophic osteoarthropathy: its modification by therapy.
    Lopez-Majano V, Layon J, Britt T.
    Eur J Nucl Med; 1982 Jul 28; 7(9):419-21. PubMed ID: 7128632
    [No Abstract] [Full Text] [Related]

  • 16. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma.
    Decker DA, Dines DE, Payne WS, Bernatz PE, Pairolero PC.
    Chest; 1978 Dec 28; 74(6):640-2. PubMed ID: 216532
    [Abstract] [Full Text] [Related]

  • 17. Pneumocystis carinii pneumonitis in patients with lung cancer.
    Fossieck BE, Spagnolo SV.
    Chest; 1980 Nov 28; 78(5):721-2. PubMed ID: 6253235
    [Abstract] [Full Text] [Related]

  • 18. ENDOCRINE AND METABOLIC ASPECTS OF BRONCHOGENIC CARCINOMA.
    BORUCHOW IB.
    Arch Surg; 1965 Jan 28; 90():101-8. PubMed ID: 14220623
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.